MUC1 and sarcoidosis: Biomarkers such as soluble interleukin-2 receptor (sIL-2R), chitotriosidase, KL-6, and neopterin have all shown promise in monitoring sarcoidosis activity and could be considered for integration into future versions of the score [27-29].